The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2) - Schwarz, M; Nordt, T; Bode, C (Thromb Res, 2002)
et al.